These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2289996)

  • 1. Impact of dosage schedule of antibiotics on the treatment of serious infections.
    Bakker-Woudenberg IA; Roosendaal R
    Intensive Care Med; 1990; 16 Suppl 3():S229-34. PubMed ID: 2289996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the antibiotic dosage schedule on efficacy in experimental lung infections.
    Roosendaal R; Bakker-Woudenberg IA
    Scand J Infect Dis Suppl; 1990; 74():155-62. PubMed ID: 2097704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis.
    Carbon C
    Scand J Infect Dis Suppl; 1990; 74():163-72. PubMed ID: 2097705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics.
    Toutain PL; del Castillo JR; Bousquet-Mélou A
    Res Vet Sci; 2002 Oct; 73(2):105-14. PubMed ID: 12204627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What preclinical data are needed to justify once-daily therapy?
    Bergeron MG
    J Clin Pharmacol; 1992 Aug; 32(8):698-705. PubMed ID: 1487558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of antimicrobial activity.
    Vogelman B; Craig WA
    J Pediatr; 1986 May; 108(5 Pt 2):835-40. PubMed ID: 3701535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily versus multiple-daily dosing of aminoglycosides.
    Craig WA
    J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral aminoglycoside therapy. Selection, administration and monitoring.
    Kumana CR; Yuen KY
    Drugs; 1994 Jun; 47(6):902-13. PubMed ID: 7521830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose antibiotic therapy: what has the past taught us?
    Carbón C
    J Clin Pharmacol; 1992 Aug; 32(8):686-91. PubMed ID: 1487556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials.
    Kasiakou SK; Sermaides GJ; Michalopoulos A; Soteriades ES; Falagas ME
    Lancet Infect Dis; 2005 Sep; 5(9):581-9. PubMed ID: 16122681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment].
    Bellmann R
    Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):162-6. PubMed ID: 24643839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
    Burgess DS
    Chest; 1999 Mar; 115(3 Suppl):19S-23S. PubMed ID: 10084455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single daily dose therapy with aminoglycosides.
    Nordström L; Lerner SA
    J Hosp Infect; 1991 Jun; 18 Suppl A():117-29. PubMed ID: 1679774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicologic and pharmacologic considerations in the choice of empiric parenteral antibiotics.
    Glauser MP; Neftel KA
    Am J Med; 1986 May; 80(5C):64-9. PubMed ID: 3717190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.